Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s stock price fell 8.1% during mid-day trading on Monday . The stock traded as low as $23.50 and last traded at $23.57. 47,938 shares were traded during mid-day trading, a decline of 25% from the average session volume of 63,740 shares. The stock had previously closed at $25.65.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings began coverage on Anbio Biotechnology in a report on Monday, January 26th. They set a “sell (d+)” rating on the stock. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Anbio Biotechnology has a consensus rating of “Sell”.
Read Our Latest Stock Report on Anbio Biotechnology
Anbio Biotechnology Trading Down 9.3%
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Read More
- Five stocks we like better than Anbio Biotechnology
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
